New UC Davis study finds relationship between tumor microbiome and immune system in patients with soft tissue sarcoma (SACRAMENTO)In a significant new study, UC Davis Comprehensive…
Read More
Today, more than 80% of children diagnosed with cancer are alive 5 years after treatment. This is one of the biggest successes of pediatric medicine…
Read More
On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adult and pediatric patients 2 years of age and…
Read More